Cell transplantation therapy for spinal cord injury
By P. Assinck, G. Duncan, Brett J. Hilton, Jason R. Plemel, W. Tetzlaff. Nature Neuroscience, 2017
802 citations recorded by the source corpus.
Subfields: Cellular and Molecular Neuroscience, Genetics, Pathology and Forensic Medicine
View Paper: https://www.semanticscholar.org/paper/44537c9a0a4d4672e5e6acc7f010ba8484b5badf
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cellular and Molecular Neuroscience
Citations in the corpus
- The Biology of Regeneration Failure and Success After Spinal Cord Injury. (2018, background): “The inflammatory post-SCI environment, for example, can be modulated by systemic, trophic factor producing stem cells (13) such as multipotential adult progenitor cell treatment (FIGURE 3E) to confer neuroprotection (89, 309, 385, 404) [possibly via their effects in the spleen (88)] and to promote n”
- Spinal cord injury: molecular mechanisms and therapeutic interventions (2023, background): “Regeneration can also be accentuated by combining cells with biomaterials or neurotrophic factors.(327) For instance, Schwann cells combined with neurotrophins, elevation of cyclic AMP levels, olfactory ensheathing cells, a steroid or chondroitinase,(328) NSCs expressing embedded into fibrin matrice”